Zacks Investment Research on MSN
CareDx launches AlloSeq Nano for high-resolution rapid HLA typing
CareDx CDNA recently announced the launch of AlloSeq Nano, a nanopore-based HLA (human leukocyte antigen) and ABO genotyping ...
To understand more fully the role of RNA and its modifications in living systems, researchers will need robust, reproducible, and accessible tools and techniques capable of identifying all RNA ...
Years of experiments and databases filled with RNA-seq results belie the simple reality that, until fairly recently, it was impossible to analyze RNA directly. The RNA-seq studies performed with ...
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...
Single cell sequencing is a powerful technique for revealing hidden complexity within cell populations. The technique has found widespread adoption in fields such as immunology, neuroscience, and ...
This article and associated images are based on a poster originally authored by Marisa Amato and presented at ELRIG Drug Discovery 2025 in affiliation with Singleron Biotechnologies GmbH. This poster ...
Complete the form below to access this White Paper, which explores how to sequence full-length cDNA and native RNA with Oxford Nanopore sequencing. Legacy sequencing technologies have made ...
To celebrate its addition to PacBio’s (CA, USA) Compatible Partner Program, ArgenTag (NY, USA) has announced the opening of a grant program to provide access to single-cell sequencing tech, free of ...
A $20 million federal civil suit filed by a biotechnology startup charges that a Columbia University researcher associated with the company breached his duties as a corporate official by helping to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results